 |
|
Professor Dr. med. Peter Boekstegers |
 |
| |
Klinikum Großhadern |
|
| |
Internal Medicine I |
|
| |
Ludwig Maximilian University Munich |
|
| |
Marchioninistr. 15 |
|
| |
D-81377 Munich |
|
| |
Present position: Executive senior physician and staff senior physician
Date of birth: 25 Feb. 1961
Nationality: German |
|
Education: |
|
| 1980-1986 |
|
1980-1986 Study of human medicine at the Freie Universität Berlin, Friedrich-Wilhelm-University Bonn, Eberhardt-Karls-University Tübingen and Georg-August-University Göttingen |
|
| 1986 |
|
Approbation |
|
| 1984-1987 |
|
Thesis, at the Eberhardt-Karls-University Tübingen |
|
| 1994 |
|
Habilitation at the Klinikum Großhadern, Dep. of Internal Medicine I, Ludwig-Maximilians-University Munich |
|
| 2002 |
|
C3 professorship Internal Medicine |
|
| |
Authorization to practice medicine: 1986
|
Relevant previous positions:
|
| 1986-1988 |
|
Scientific assistant at the Institute of Physiology, University of Medicine, Lübeck
Scientific assistant at the Klinikum Großhadern, Dep. of Internal Medicine I, Ludwig-Maximilians-University Munich |
|
| Since 1991 |
|
Execution of diagnostic intracardiac catheters with PTCA and stent implantation |
|
| 1993 |
|
Approval as internist |
|
| 1995 |
|
Approval as cardiologist |
|
| 1999-2003 |
|
Senior physician of the intensive care unit |
|
| 2000 |
|
Executive of the Research Laboratories of the Internal Medicine I |
|
| Since 2000 |
|
Executive of the catheter laboratory of the Internal Medicine I |
|
| Since 2003 |
|
Executive senior physician and staff senior physician |
|
| |
|
Experience in clinical research/therapeutic area:
|
 |
- Principle investigator multy center study: Adjunctive Treatment with the VCABTM/VSTENTTM Myocardial Implant System in CABAG Patients (ADVANTAGE)
- Clinical multi center study: Catheter based therapy for hypertrophic obstructive cardiomyopathy. (HOCM)
- Clinical multi center study: CLASSICS: Clopidogrel after Stentimplantation, Clopidogrel Aspirin Stent International Co-operative Study
- Clinical multi center study: BRAVO: Oral application of an GPIIB/IIA-Antagonist
- Clinical multi center study: VELVET: Direct Stenting versus Predilatation : direct Stenting with the BXTM VelocityTM ballonexpandable stent mounted on the raptor R rapid exchange delivery system versus predilatation in an European randomiszed Trial
- Clinical study: Treatment of patient with acute myodardial infarction: Myoprotect II
- Clinical study: Prospetive randomized clinical study in high risk patients undergoing PTCA/Stentimplantation versus bypass surgery: Myoprotect I
- Sirolimusstent versus Bypassoperation (Syntax-study)
- Clinical multi center study: Comparison of medical treatment after stentimplantation MATTIS
|
|